ClinicalTrials.gg
Not yet recruitingNCT06093087Updated Oct 23, 2023

Randomized Controlled Trial of Internal Fixation Reconstruction With Stent Screw in the Treatment of Kummell's Disease

A Phase 1/2 interventional study of SAIF and BKP in BKP, Osteoporotic Vertebral Compression Fracture and Kummell's Disease, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. Not yet recruiting. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2023-10-23.

Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University · Phase 1/2, Interventional, and Treatment

Phase
Phase 1/2
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

This study is a multicenter, prospective, double-blind, randomized controlled trial using a parallel two-arm design to investigate whether the postoperative 6-month quality of life, vertebral stability, complication of patients with osteoporotic vertebral compression fractures (Kummell's disease) are better with the use of stent screw internal fixation and percutaneous bone cement reconstruction technique compared to patients undergoing traditional percutaneous balloon kyphoplasty (BKP) for vertebral augmentation

02

Conditions studied

  • BKP
  • Osteoporotic Vertebral Compression Fracture
  • Kummell's Disease
  • Stent-screw-assisted Internal Fixation

Browse trials for

03

In context

Fractures, Compression

50 studies on the registry are indexed under Fractures, Compression; 10 are open to participants now.

This study's planned enrollment of 70 is close to the median of 73 across 32 interventional studies indexed under Fractures, Compression.

Browse Fractures, Compression studies →

Lead sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University is the lead sponsor of 1,047 studies on the registry; 502 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 60 or above, gender not specified.
  • Must have one to three vertebral segments with vertebral compression fracture (VCF) located between T5 and L5, attributed to underlying primary or secondary osteoporosis rather than cancer.
  • All VCFs must exhibit the following radiographic changes: according to Genant's criteria, acute (≤4 months) decrease in anterior, middle, or posterior vertebral height by at least one grade (20-25% reduction in vertebral height, 10-20% reduction in vertebral area) compared to previous X-ray, CT, or MRI results.
  • All VCFs for treatment must occur within four months or less.
  • All VCFs for treatment must be technically feasible and clinically suitable for BKP or SAIF surgery.
  • Pre-treatment back pain NRS score must be ≥ 7 and ineffective with conservative (non-surgical) treatment.
  • Pre-treatment Oswestry Disability Index must be ≥ 30 (on a scale of 0-100).
  • Patient's must be ≥ 12 months.
  • Must declare willingness to participate in all post-operative follow-ups.
  • Must be capable of understanding the risks and benefits of the study and willing to provide written .

Exclusion criteria

Exclusion Criteria:

  • Vertebral morphology or fracture morphology unsuitable for balloon kyphoplasty. VCF caused by high-energy trauma.
  • Asymptomatic VCF or vertebral bodies amenable to prophylactic treatment.
  • VCF at the same site associated with primary bone tumors.
  • Back pain caused by reasons other than acute fractures. VCF with an estimated fracture time of more than 4 months, based on clinical assessment (radiological evidence and patient history).
  • VCF associated with secondary radiculopathy or neurological compromise.
  • VCF requiring spinal surgery other than BKP or SAIF.
  • Spinal cord compression or vertebral canal injury requiring decompression surgery.
  • Combined clinical conditions unsuitable for surgery or affecting subsequent long-term data collection or follow-up.
  • Allergy to any component during the surgical procedure (e.g., bone cement, contrast agents).
  • Concurrent participation in another clinical study.
  • Pregnancy during the study or planning to become pregnant.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Phase 1 / Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    SAIF

    patients will be treated with kyphoplasty surgery combined with pedicular screw-assisted internal fixation for vertebral augmentation

    Procedure: SAIF

  • Active comparator
    BKP

    patients will be treated with balloon kyphoplasty surgery for vertebral augmentation

    Procedure: BKP

Interventions

  • ProcedureSAIF

    The patient was placed in a prone position under general anesthesia. Using a C-arm X-ray machine and a positioning plate for navigation, the target position on the vertebral body was located one the surface of the body. The puncture needle core was withdrawn after puncturing, and a guide needle was inserted. After removing the puncture needle sleeve, a hollow bone cement screw was screwed into the anterior column of the vertebral body through the guide needle. Subsequently, bone cement was injected into the appropriate position through the bone cement screw to restore the vertebral height

  • ProcedureBKP

    The patient was placed in a prone position after general anesthesia. Using a C-arm X-ray machine and a positioning plate for guidance, the target position on the vertebral body was located from the surface of the body. A puncture needle sleeve was inserted into the vertebral body. A PKP balloon was then inserted to perform vertebral restoration. After removing the balloon, an appropriate amount of bone cement was injected to ensure even distribution within the vertebral body. Vertebral height augmentation and restoration will then be achieved.

06

What researchers measure

Primary outcomes

  1. ODI score

    Each patients were asked to complete the Oswestry Disability Index questionnaire postoperatively during follow up

    Time frame: ODI score measured 1,3,6 months post surgery during follow up

Secondary outcomes

  1. CT imaging indicators related to vertebral body stability

    There are total 5 indicators measured based on CT images: Anterior vertebral height (ant VBH), middle vertebral height (mid VBH), posterior vertebral height (post VBH), vertebral kyphosis angle (VKA), local kyphosis angle (LKA)

    Time frame: all variables were measured 1,3,6 months post surgery during follow up

  2. SF36 score

    SF-36 questionnaire aimed at two different constructs to measure health-related quality of life: the Physical Component and the Mental Component

    Time frame: measured 1,3,6 months post surgery during follow up

  3. VAS score

    The Visual Analogue Scale (VAS) measures pain intensity. 0 indicates no pain and 10 indicates pain as bad as it could possibly be

    Time frame: measured 1,3,6 months post surgery during follow up

  4. EQ-5D score

    The EQ-5D descriptive system measure with one question for each of the five dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.

    Time frame: measured 1,3,6 months post surgery during follow up

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 23, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06093087
Responsible party
Sponsor
First posted
Oct 23, 2023
Start date
Jan 1, 2024 (estimated)
Primary completion
Jan 1, 2027 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Oct 23, 2023

Study contacts

Wanli Li, MD
Contact
liwanli@zju.edu.cn
+86 13967116021

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion